Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1991 Apr;213(4):297–307. doi: 10.1097/00000658-199104000-00004

Have changing treatment patterns affected outcome for operable breast cancer? Ten-year follow-up in 1288 patients, 1965 to 1978.

H S Cody 3rd 1, E H Laughlin 1, C Trillo 1, J A Urban 1
PMCID: PMC1358348  PMID: 2009011

Abstract

From 1965 to 1978, 1288 patients with primary operable breast cancer were treated by the senior author, using extended radical (ERM), radical (RM), and modified radical (MRM) mastectomy operations exclusively. Results were analyzed for trends in overall and disease-free survival, and patterns of local and distant relapse, the years 1965 to 1970 versus 1971 to 1974 versus 1975 to 1978. Significant changes (p less than 0.00001) from 1965 to 1978 included progressively earlier stage of disease, less frequent use of RM and ERM, a decline in the use of postoperative radiotherapy, and the introduction in 1975 of multidrug adjuvant chemotherapy. Ten-year disease-free survival rates improved significantly for all patients (by 11%, p = 0.00004) and for node-negative (by 12%, p = 0.0024), node-positive (by 8%, p = 0.012), clinical stage II (by 15%, p = 0.0022), and pathologic stage II (by 12%, p = 0.016) disease. Ten-year local recurrence for all patients was 3% (local only) and 2% (local with distant metastasis), and survival from date of recurrence for all patients failing treatment increased two times (p less than 0.0001) for patients treated most recently. As the primary surgical treatment of breast cancer continues to become more moderate, the promise of systemic adjuvant therapies can be realized only with continued emphasis on earlier diagnosis and maximal local control of disease.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Brusamolino E., Valagussa P., Rossi A., Brugnatelli L., Brambilla C., De Lena M., Tancini G., Bajetta E., Musumeci R. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976 Feb 19;294(8):405–410. doi: 10.1056/NEJM197602192940801. [DOI] [PubMed] [Google Scholar]
  2. Carter C. L., Allen C., Henson D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989 Jan 1;63(1):181–187. doi: 10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  3. Cody H. S., 3rd, Bretsky S. S., Urban J. A. The continuing importance of adequate surgery for operable breast cancer: significant salvage of node-positive patients without adjuvant chemotherapy. CA Cancer J Clin. 1982 Jul-Aug;32(4):242–256. doi: 10.3322/canjclin.32.4.242. [DOI] [PubMed] [Google Scholar]
  4. Cuzick J., Stewart H., Peto R., Baum M., Fisher B., Host H., Lythgoe J. P., Ribeiro G., Scheurlen H., Wallgren A. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987 Jan;71(1):15–29. [PubMed] [Google Scholar]
  5. Fisher B. Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res. 1980 Nov;40(11):3863–3874. [PubMed] [Google Scholar]
  6. Fisher B., Redmond C., Fisher E. R., Bauer M., Wolmark N., Wickerham D. L., Deutsch M., Montague E., Margolese R., Foster R. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985 Mar 14;312(11):674–681. doi: 10.1056/NEJM198503143121102. [DOI] [PubMed] [Google Scholar]
  7. Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., Fisher E., Deutsch M., Caplan R., Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822–828. doi: 10.1056/NEJM198903303201302. [DOI] [PubMed] [Google Scholar]
  8. Harris J. R., Recht A., Amalric R., Calle R., Clark R. M., Reid J. G., Spitalier J. M., Vilcoq J. R., Hellman S. Time course and prognosis of local recurrence following primary radiation therapy for early breast cancer. J Clin Oncol. 1984 Jan;2(1):37–41. doi: 10.1200/JCO.1984.2.1.37. [DOI] [PubMed] [Google Scholar]
  9. Hayward J., Caleffi M. The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award. Arch Surg. 1987 Nov;122(11):1244–1247. doi: 10.1001/archsurg.1987.01400230030004. [DOI] [PubMed] [Google Scholar]
  10. Lacour J., Lê M. G., Hill C., Kramar A., Contesso G., Sarrazin D. Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol. 1987 Aug;13(4):309–314. [PubMed] [Google Scholar]
  11. Maddox W. A., Carpenter J. T., Jr, Laws H. T., Soong S. J., Cloud G., Balch C. M., Urist M. M. Does radical mastectomy still have a place in the treatment of primary operable breast cancer? Arch Surg. 1987 Nov;122(11):1317–1320. doi: 10.1001/archsurg.1987.01400230103018. [DOI] [PubMed] [Google Scholar]
  12. Meier P., Ferguson D. J., Karrison T. A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer. 1989 Jan 1;63(1):188–195. doi: 10.1002/1097-0142(19890101)63:1<188::aid-cncr2820630130>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  13. Ross M. B., Buzdar A. U., Smith T. L., Eckles N., Hortobagyi G. N., Blumenschein G. R., Freireich E. J., Gehan E. A. Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer. 1985 Jan 15;55(2):341–346. doi: 10.1002/1097-0142(19850115)55:2<341::aid-cncr2820550206>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  14. Silverberg E., Boring C. C., Squires T. S. Cancer statistics, 1990. CA Cancer J Clin. 1990 Jan-Feb;40(1):9–26. [PubMed] [Google Scholar]
  15. URBAN J. A., BAKER H. W. Radical mastectomy in continuity with en bloc resection of the internal mammary lymph-node chain; a new procedure for primary operable cancer of the breast. Cancer. 1952 Sep;5(5):992–1008. doi: 10.1002/1097-0142(195209)5:5<992::aid-cncr2820050515>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  16. URBAN J. A. Clinical experience and results of excision of the internal mammary lymph node chain in primary operable breast cancer. Cancer. 1959 Jan-Feb;12(1):14–22. doi: 10.1002/1097-0142(195901/02)12:1<14::aid-cncr2820120106>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  17. Urban J. A., Castro E. B. Selecting variations in extent of surgical procedure for breast cancer. Cancer. 1971 Dec;28(6):1615–1623. doi: 10.1002/1097-0142(197112)28:6<1615::aid-cncr2820280642>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  18. Urban J. A. Management of operable breast cancer: the surgeon's view. Cancer. 1978 Oct;42(4):2066–2077. doi: 10.1002/1097-0142(197810)42:4<2066::aid-cncr2820420458>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  19. Veronesi U., Banfi A., Del Vecchio M., Saccozzi R., Clemente C., Greco M., Luini A., Marubini E., Muscolino G., Rilke F. Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol. 1986 Sep;22(9):1085–1089. doi: 10.1016/0277-5379(86)90011-8. [DOI] [PubMed] [Google Scholar]
  20. Veronesi U., Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer. 1981 Jan 1;47(1):170–175. doi: 10.1002/1097-0142(19810101)47:1<170::aid-cncr2820470128>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  21. Wilson R. E., Donegan W. L., Mettlin C., Natarajan N., Smart C. R., Murphy G. P. The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet. 1984 Oct;159(4):309–318. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES